Refractory Medulloblastoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09037Pembrolizumab1Recruiting1
DB12048Savolitinib1Recruiting1
DB04690Camptothecin1 / 2Active Not Recruiting1
DB00762Irinotecan1 / 2Active Not Recruiting1
DB13985Lutetium Lu 177 dotatate1 / 2Not Yet Recruiting1
DB11740MK-17751 / 2Active Not Recruiting1
DB00112Bevacizumab2Completed1
DB04690Camptothecin2Completed1
DB14860Ensartinib2Recruiting2
DB12147Erdafitinib2Recruiting1
DB15127Hydrogen2Recruiting1
DB00762Irinotecan2Completed1
DB14568Ivosidenib2Recruiting1
DB12167LY-30234142Recruiting1
DB14723Larotrectinib2Recruiting1
DB14123Menthol2Recruiting1
DB09074Olaparib2Active Not Recruiting1
DB09074Olaparib2Recruiting1
DB09073Palbociclib2Active Not Recruiting1
DB09073Palbociclib2Recruiting1
DB15685Selpercatinib2Recruiting2
DB11689Selumetinib2Recruiting1
DB14546Sulfate ion2Recruiting1
DB12887Tazemetostat2Active Not Recruiting1
DB12887Tazemetostat2Recruiting1
DB00853Temozolomide2Completed1
DB04960Tipifarnib2Recruiting2
DB13930Ulixertinib2Active Not Recruiting1
DB13930Ulixertinib2Recruiting1
DB08881Vemurafenib2Recruiting1
DB13104X-3962Recruiting2